Integrated BioTherapeutics Overview

  • Founded
  • 2005
  • Status
  • Private
  • Employees
  • 35
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $543K
Latest Deal Amount
  • Investors
  • 9

Integrated BioTherapeutics General Information


Developer of toxin-based vaccines intended to help control infectious diseases. The company's vaccines can protect against all ebolaviruses, a common cause of both hospital-acquired and community-acquired infections and bacterial sepsis and also discovery novel vaccines and therapeutics, enabling healthcare providers to treat emerging infectious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 4 Research Court
  • Suite 300
  • Rockville, MD 20850
  • United States
+1 (877) 000-0000

Integrated BioTherapeutics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Integrated BioTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt - PPP 28-Apr-2020 $543K 00.000 Completed Generating Revenue
8. Later Stage VC 06-Jan-2020 00.00 00.000 Completed Generating Revenue
7. Grant 01-Jan-2020 00.000 0000 Completed Generating Revenue
6. Grant 01-Aug-2017 00.00 0000 Completed Generating Revenue
5. Grant 01-Jan-2016 00.000 0000 Completed Generating Revenue
4. Grant 22-Aug-2012 00.000 0000 Completed Generating Revenue
3. Debt - General 29-Jun-2011 0000 Completed Generating Revenue
2. Accelerator/Incubator 12-Aug-2010 $75K Completed Generating Revenue
1. Early Stage VC 17-Sep-2008 $75K $75K Completed Startup
To view Integrated BioTherapeutics’s complete valuation and funding history, request access »

Integrated BioTherapeutics Executive Team (3)

Name Title Board Seat Contact Info
M. Javad Aman Ph.D Co-Founder, Chief Scientific Officer and President
Gary Nabors Chief Development Officer & Executive Vice President
You’re viewing 2 of 3 executive team members. Get the full list »

Integrated BioTherapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Integrated BioTherapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novo Holdings Venture Capital Minority 000 0000 000000 0
CARB-X University 000 0000 000000 0
National Institute Of Allergy and Infectious Diseases Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
United States Army Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »